RE:Shares and dealsDoccole wrote: No question I am holding my shares right to the chest!
any comparables to a expected partnership out there? It's easy if they sell the drug for 2b, then we know what to expect per share. What about other deals?
I don't know a lot about partnerships so any info is appreciated! Bring 2021!
Good question Doccole.
As per Dan, we now have a 70% chance of a partnership.
Here's my guess ...
I would assume 3-4 partners in total ... one for Europe, one for USA, one for Japan and one for Rest-of-World (or something like that).
Upfront cash to cover P3 and some cash in the bank.
Royalties to be 10%-15%, depending on upfront cash outlay.
These partners may also have right of first refusal for future drugs.
Maybe a break fee should ATE choose to go a different route.
ATE to take this as a "floor" into discussions with Big Pharma.
Demand is high and one Big Pharma makes a bid for the full monty.
That's my guess ... could be 3-4 partners, might be one company to buy the first drug, might be an all-out acquisition to secure the future riches. We should assume the first and hope for the third.